← Back to discover
httpcdp
magent
Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.
Resource URL
https://api.magentlab.com/api/calc/nccn_ipi
Payment options
exactBase (8453)
$0.005 USDC
Max amount
- Pay to
- 0x836Be278f1739fB4308091cD1852F7971Bc19Ee2
- Timeout
- 600s
Tags
nccn-ipilymphomahematologydlbclprognosis
For agents
Prompt snippet for AI agents
Find and pay for this x402 resource: URL: https://api.magentlab.com/api/calc/nccn_ipi Type: http Sources: cdp